Replies to post #666617 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

So the way I see this as a layman, is that, as Hoffman pointed out, NWBO could finally use the name Murcidencel by November 29, 2023, and, as I reason, that makes the MAA (marketing application) submitted on December 20, 2023, internationally identifiable for collaborative purposes — regardless of whether or not Orbis is being applied.

Moreover, as ChatGPT discusses, resultant publication of that name (which Hoffman points out will occur sometime around January 28, 2024) will allow international interaction to take place without the confusion some naysayers attempted to germinate related to DCVax-l’s standardized unique name — Murcidencel.